Crosstree Capital Partners provides expert M&A and strategic advisory for healthcare and life sciences, driving value and growth inorganic growth

Meet Crosstree Capital's senior leadership team. Connect with us today to find out how we could parner in the future.

Read more about Crosstree Capital, the premiere provider of investment banking services for Health Sciences organizations globally.

Crosstree’s Client Outcomes Consistently Exceed Industry Benchmarks Crosstree’s deep industry focus fosters efficient project execution. Our relationships with investors and strategic buyers …

2023年10月24日 · Crosstree consistently closes more Pharma Services transactions globally than any other M&A advisor, and the addition of Sandra and three new investment banking …

TAMPA, FLORIDA (March 21, 2023) – Crosstree, a global leader in health sciences M&A, proudly unveils its refreshed brand image, signaling a pivotal moment in its continued transformation. …

Crosstree is one of a handful of healthcare investment banking firms with dedicated coverage to the Digital Health sector. Our long-term, industry-focused relationships empower us with …

Jeff Ellis co-founded Crosstree Capital Partners in 2004 and is responsible for leading the firm’s coverage of diagnostic products and services, life sciences tools, and pharmaceutical testing …

Exlore Crosstree's most recently closed investment banking deals in the pharma services, diagnostics and tools, and healthcare technology industries.

Crosstree is a global leader in Health Sciences M&A. Our entrepreneurial culture is the ideal environment for professionals looking for a challenging and rewarding career.